The Oncosearch | Oncotarget

PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop Research Paper

Michael Selitrennik, Sima Lev

Published Jun 10, 2015 · Vol. 6, No. 26 · pp. 22214-22226

Identification of novel long non-coding RNAs in triple-negative breast cancer Research Paper

Xiaokun Shen, Bojian Xie, Zhaosheng Ma, Wenjie Yu, Wenmin Wang, Dong Xu, Xinqiang Yan, Beibei Chen, Longyao Yu, Jicheng Li, Xiaobing Chen, Kan Ding, Feilin Cao

Published Jun 10, 2015 · Vol. 6, No. 25 · pp. 21730-21739

p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways Priority Research Paper

Maria Shatz, Igor Shats, Daniel Menendez, Michael A. Resnick

Published Jun 10, 2015 · Vol. 6, No. 19 · pp. 16963-16980

Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis Research Paper

Michael W. Pickup, Laura D. Hover, Yan Guo, Agnieszka E. Gorska, Anna Chytil, Sergey V. Novitskiy, Harold L. Moses, Philip Owens

Published Jun 10, 2015 · Vol. 6, No. 26 · pp. 22890-22904

Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells Review

Ashleigh R. Poh, Robert J.J. Oâ€™Donoghue, Matthias Ernst

Published Jun 10, 2015 · Vol. 6, No. 18 · pp. 15752-15771

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy Priority Research Paper

Erika Vacchelli, Michaela Semeraro, David P. Enot, Kariman Chaba, Vichnou Poirier Colame, Peggy Dartigues, Aurelie Perier, Irene Villa, Sylvie Rusakiewicz, Caroline Gronnier, Diane GoÃ©rÃ©, Christophe Mariette, Laurence Zitvogel, Guido Kroemer

Published Jun 10, 2015 · Vol. 6, No. 25 · pp. 20840-20850

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells Priority Research Paper

Arianna De Luca, Marco Fiorillo, Maria Peiris-PagÃ¨s, Bela Ozsvari, Duncan L. Smith, Rosa Sanchez-Alvarez, Ubaldo E. Martinez-Outschoorn, Anna Rita Cappello, Vincenzo Pezzi, Michael P. Lisanti, Federica Sotgia

Published Jun 9, 2015 · Vol. 6, No. 17 · pp. 14777-14795

The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis Research Paper

Lingyun Zhang, Yuee Teng, Yibo Fan, Yan Wang, Wei Li, Jing Shi, Yanju Ma, Ce Li, Xiaonan Shi, Xiujuan Qu, Yunpeng Liu

Published Jun 8, 2015 · Vol. 6, No. 26 · pp. 22918-22933

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression Research Paper

MarÃa Laura Polo, Marina Riggio, MarÃa May, MarÃa Jimena RodrÃguez, MarÃa Cecilia Perrone, Melody Stallings-Mann, Diego Kaen, Marlene Frost, Matthew Goetz, Judy Boughey, Claudia Lanari, Derek Radisky, Virginia Novaro

Published Jun 8, 2015 · Vol. 6, No. 26 · pp. 22081-22097

Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis Research Paper

Fengmei Chao, Jun Zhang, Yang Zhang, Houli Liu, Chenchen Yang, Juan Wang, Yanjun Guo, Xiaohong Wen, Kaiye Zhang, Bei Huang, Daihai Liu, Yong Li

Published Jun 8, 2015 · Vol. 6, No. 27 · pp. 23496-23509

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis Research Paper

Jino Park, Michaela Schlederer, Martin Schreiber, Ryan Ice, Olaf Merkel, Martin Bilban, Sebastian Hofbauer, Soojin Kim, Joseph Addison, Jie Zou, Chunyan Ji, Silvia T. Bunting, Zhengqi Wang, Menachem Shoham, Gang Huang, Zsuzsanna Bago-Horvath, Laura F. Gibson, Yon Rojanasakul, Scot Remick, Alexey Ivanov, Elena Pugacheva, Kevin D. Bunting, Richard Moriggl, Lukas Kenner, William Tse

Published Jun 7, 2015 · Vol. 6, No. 24 · pp. 20697-20710

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform Research Paper

Kathrin Schaal, Marc Hirschfeld, Peter Bronsert, Hannah FÃ¼llgraf, Markus JÃ¤ger, Bettina Herde, Claudia NÃ¶thling, Sebastian Mayer, Thalia Erbes, Elmar Stickeler

Published Jun 5, 2015 · Vol. 6, No. 26 · pp. 22553-22563

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis Research Paper

Noemi Perez-Janices, Idoia Blanco-Luquin, Natalia Torrea, Therese Liechtenstein, David Escors, Alicia Cordoba, Francisco Vicente-Garcia, Isabel Jauregui, Susana De La Cruz, JosÃ© Juan Illarramendi, Valle Coca, Maria Berdasco, Grazyna Kochan, Berta IbaÃ±ez, JosÃ© Miguel Lera, David Guerrero-Setas

Published Jun 4, 2015 · Vol. 6, No. 27 · pp. 23944-23958

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation Research Paper

Monica Faronato, Van T.M. Nguyen, Darren K. Patten, Ylenia Lombardo, Jennifer H. Steel, Naina Patel, Laura Woodley, Sami Shousha, Giancarlo Pruneri, R. Charles Coombes, Luca Magnani

Published Jun 4, 2015 · Vol. 6, No. 26 · pp. 22467-22479

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target Research Paper

Bashar Zeidan, Thomas R. Jackson, Samantha E.T. Larkin, Ramsey I. Cutress, Gary R. Coulton, Margaret Ashton-Key, Nick Murray, Graham Packham, Vassilis Gorgoulis, Spiros D. Garbis, Paul A. Townsend

Published Jun 4, 2015 · Vol. 6, No. 25 · pp. 21421-21427

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy Research Paper

Mohammad T. Malik, Martin G. Oâ€™Toole, Lavona K. Casson, Shelia D. Thomas, Gina T. Bardi, Elsa Merit Reyes-Reyes, Chin K. Ng, Kyung A. Kang, Paula J. Bates

Published Jun 3, 2015 · Vol. 6, No. 26 · pp. 22270-22281

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial Clinical Research Papers

Liang Huang, Sheng Chen, Wentao Yang, Binghe Xu, Tao Huang, Hongjian Yang, Hong Zheng, Yongsheng Wang, Erwei Song, Jin Zhang, Shude Cui, Da Pang, Lili Tang, Yutao Lei, Cuizhi Geng, Zhiming Shao

Published Jun 2, 2015 · Vol. 6, No. 21 · pp. 18683-18692

DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer Research Paper

Chia-Yi Su, Tsung-Chieh Lin, Yuan-Feng Lin, Ming-Huang Chen, Chien-Hsin Lee, Hsuan-Yao Wang, Yu-Chieh Lee, Yu-Peng Liu, Chi-Long Chen, Michael Hsiao

Published Jun 2, 2015 · Vol. 6, No. 21 · pp. 18602-18612

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers Research Paper

Tarek M.A. Abdel-Fatah, Arvind Arora, Paul M. Moseley, Christina Perry, Emad A. Rakha, Andrew R. Green, Stephen Y.T. Chan, Ian O. Ellis, Srinivasan Madhusudan

Published Jun 1, 2015 · Vol. 6, No. 26 · pp. 21964-21978

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases Research Paper

Adam G. Johnson, Jimmy Ruiz, Ryan Hughes, Brandi R. Page, Scott Isom, John T. Lucas, Emory R. McTyre, Kristin W. Houseknecht, Diandra N. Ayala-Peacock, J. Daniel Bourland, William H. Hinson, Adrian W. Laxton, Stephen B. Tatter, Waldemar Debinski, Kounosuke Watabe, Michael D. Chan

Published Jun 1, 2015 · Vol. 6, No. 22 · pp. 18945-18955

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop Research Paper

Identification of novel long non-coding RNAs in triple-negative breast cancer Research Paper

p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways Priority Research Paper

Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis Research Paper

Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells Review

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy Priority Research Paper

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells Priority Research Paper

The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis Research Paper

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression Research Paper

Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis Research Paper

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis Research Paper

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform Research Paper

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis Research Paper

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation Research Paper

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target Research Paper

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy Research Paper

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial Clinical Research Papers

DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer Research Paper

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers Research Paper

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop Research Paper

Identification of novel long non-coding RNAs in triple-negative breast cancer Research Paper

p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways Priority Research Paper

Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis Research Paper

Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells Review

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy Priority Research Paper

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells Priority Research Paper

The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis Research Paper

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression Research Paper

Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis Research Paper

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis Research Paper

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform Research Paper

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis Research Paper

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation Research Paper

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target Research Paper

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy Research Paper

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial Clinical Research Papers

DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer Research Paper

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers Research Paper

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases Research Paper